Antiva Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Antiva Biosciences Inc (Antiva) formerly Hera Therapeutics Inc, is a clinical stage bio-pharmaceutical company focused on the development of novel medicines for the treatment of diseases caused by human papillomavirus (HPV) infection. Its lead product candidate ABI-1968, is a double prodrug of an acyclic nucleoside phosphonate which blocks HPV replication and inducing apoptosis in HPV-infected lesions, without affecting normal cells. Antiva is developing additional molecules based on its anti-viral platform targeting HIV infection, the herpes virus, cytomegalovirus, cervical dysplasia, vulvar intraepithelial neoplasia (VIN), among others. The company is funded by Brace Pharma Capital, Canaan Partners, Lumira Capital Corp, and others. Antiva Biosciences is headquartered in South San Francisco, California, the US.

Antiva Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Antiva Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antiva Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Antiva Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antiva Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Antiva Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Antiva Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Antiva Biosciences Raises USD15 Million in Series C-1 Financing 10
Antiva Biosciences Raises USD22 Million in Series C Financing 12
Antiva Biosciences Raises USD14.7 Million in Venture Financing 13
Antiva Biosciences Raises USD16 Million in Series B Financing 14
Hera Therapeutics Raises USD9 Million in Venture Financing 15
Hera Therapeutics Raises USD1 Million in Venture Financing 16
Hera Therapeutics Raises US$1 Million In Venture Financing 17
Hera Therapeutics Raises USD0.5 Million in Venture Financing 18
Equity Offering 19
Antiva Biosciences Spin Out from University of California San Diego 19
Antiva Biosciences Inc - Key Competitors 20
Antiva Biosciences Inc - Key Employees 21
Antiva Biosciences Inc - Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List Of Tables


Antiva Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Antiva Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antiva Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Antiva Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antiva Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Antiva Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Antiva Biosciences Raises USD15 Million in Series C-1 Financing 10
Antiva Biosciences Raises USD22 Million in Series C Financing 12
Antiva Biosciences Raises USD14.7 Million in Venture Financing 13
Antiva Biosciences Raises USD16 Million in Series B Financing 14
Hera Therapeutics Raises USD9 Million in Venture Financing 15
Hera Therapeutics Raises USD1 Million in Venture Financing 16
Hera Therapeutics Raises US$1 Million In Venture Financing 17
Hera Therapeutics Raises USD0.5 Million in Venture Financing 18
Antiva Biosciences Spin Out from University of California San Diego 19
Antiva Biosciences Inc, Key Competitors 20
Antiva Biosciences Inc, Key Employees 21

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Antiva Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Antiva Biosciences Inc (Antiva) formerly Hera Therapeutics Inc, is a clinical stage bio-pharmaceutical company focused on the development of novel medicines for the treatment of diseases caused by human papillomavirus

USD 250 View Report

Akers Biosciences Inc (AKER) - Product Pipeline Analysis, 2019 Update

Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its

USD 750 View Report

Angle Biosciences Inc - Product Pipeline Analysis, 2019 Update

Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors,

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available